综述:炎症性肠病中人类白细胞抗原区域的遗传学
该综述通过系统检索文献,总结人类白细胞抗原(HLA)基因在炎症性肠病(IBD)中的风险与保护作用。所有经典HLA基因均存在IBD相关基因型,HLA-DRB1*03:01是克罗恩病和溃疡性结肠炎中最相关的风险等位基因。HLA基因型还与硫嘌呤(胰腺炎)和抗TNF药物(抗体形成)的不良事件相关。
要点
- HLA-DRB1*03:01是克罗恩病和溃疡性结肠炎中最相关的风险等位基因。
- 所有经典HLA基因(A、B、C、DRB1、DQA1、DQB1、DPA1、DPB1)均存在IBD相关基因型。
- HLA基因型与硫嘌呤相关胰腺炎及抗TNF药物抗体形成等不良事件相关。
核心结论
- HLA复合体与IBD的多个风险和保护等位基因相关。
- 未来需利用长读长技术、确定杂合性并整合疾病建模以提升功能理解和临床转化。
研究设计与样本
- 采用组织化检索策略收集描述IBD(包括克罗恩病和溃疡性结肠炎)中HLA基因的文章进行综述。
主要发现
- 所有经典HLA基因(包括HLA-A、B、C、DRB1、DQA1、DQB1、DPA1和DPB1)均存在IBD相关基因型。
- HLA-DRB1是涉及最多的基因,HLA-DRB1*03:01是克罗恩病和溃疡性结肠炎中最相关的风险等位基因。
- 由于HLA基因型间高度连锁不平衡,精确阐明疾病关联具有挑战性。
- 风险等位基因致病机制是多因素的,最佳证据表明结构及静电改变影响抗原结合和下游信号传导。
- 不良药物事件与HLA基因型相关,包括硫嘌呤(胰腺炎)和抗TNF药物(抗体形成)。
临床怎么用
- HLA基因型可能有助于评估IBD患者使用硫嘌呤(胰腺炎)和抗TNF药物(抗体形成)的不良事件风险。
局限性
- HLA基因型间高度连锁不平衡使精确疾病关联的阐明具有挑战性。
- 风险等位基因致病机制是多因素的,目前最佳证据仅涉及结构及静电改变影响抗原结合和下游信号传导。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The human leucocyte antigen (HLA) complex, located at chromosome 6p21.3 is a highly polymorphic region containing the classical class I and II HLA genes. The region is highly associated with inflammatory bowel disease (IBD), largely through genome-wide association studies (GWAS). AIMS: To review the role of HLA in immune function, summarise data on risk/protective HLA genotypes for IBD, discuss the role of HLA in IBD pathogenesis, treatment and examine limitations that might be addressed by future research. METHODS: An organised search strategy was used to collate articles describing HLA genes in IBD, including Crohn's disease and ulcerative colitis. RESULTS: All classical HLA genes with variation (including HLA-A, B, C, DRB1, DQA1, DQB1, DPA1 and DPB1) harbour IBD-associated genotypes. The most implicated gene is HLA-DRB1, with HLA-DRB1*03:01 the most associated risk allele in both Crohn's disease and ulcerative colitis. Elucidating precise disease associations is challenging due to high linkage disequilibrium between HLA genotypes. The mechanisms by which risk alleles cause disease are multifactorial, with the best evidence indicating structural and electrostatic alteration impacting antigen binding and downstream signalling. Adverse medication events have been associated with HLA genotypes including with thiopurines (pancreatitis) and anti-TNF agents (antibody formation). CONCLUSIONS: The HLA complex is associated with multiple risk/protective alleles for IBD. Future research utilising long-read technology, ascertainment of zygosity and integration in disease modelling will improve the functional understanding and clinical translation of genetic findings.
引用
- Ashton JJ, Latham K, Beattie RM, et al. Review article: the genetics of the human leucocyte antigen region in inflammatory bowel disease. Aliment Pharmacol Ther. 2019. PMID: 31518029. doi:10.1111/apt.15485
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。